Skip to content

Myo-inositol/D-chiro-inositol Ratio in Follicular Fluid

Altered Myo-inositol/D-chiro-inositol Ratio in Follicular Fluid of Women Undergoing in Vitro Fertilization Has Detrimental Effects on Oocyte and Embryo Quality

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03055442
Enrollment
34
Registered
2017-02-16
Start date
2016-10-31
Completion date
2016-12-31
Last updated
2017-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Women Infertility

Brief summary

Considering the importance assumed by follicular microenvironment for a proper oocyte development, this study is a prospective observational clinical trial which aims to evaluate whether the embryo blastocyst quality may be affected by different Myo-inositol (MI) and D-chiro-inositol (DCI) levels in the follicular fluid (FF) of the aspired oocytes. The study includes egg donors and egg receiving couples participating in the oocyte donation program. MI/DCI is calculated in FF and related with blastocyst grade.

Interventions

OTHERDosage of myo-inositol

Quantitative analysis of myo-inositol was performed by gas chromatography-mass spectrometry (GC-MS)

OTHERDosage of D-chiro-inositol

Quantitative analysis of D-chiro-inositol was performed by gas chromatography-mass spectrometry (GC-MS)

Sponsors

Lo.Li.Pharma s.r.l
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 28 Years
Healthy volunteers
Yes

Inclusion criteria

* clear follicular aspirate obtained during oocyte retrieval; * each specimen of follicular fluid containing only one oocyte.

Exclusion criteria

* hyperglycaemic women; * PCOS women also if euglycaemic; * diabetic subjects having low concentrations of detectable MI in association with an anomalous MI transport.

Design outcomes

Primary

MeasureTime frameDescription
Myo-inositol concentration (µmol/l) in follicular fluid5th day from pick upAfter transvaginal aspiration of oocyte and follicular fluid and subsequent ICSI, at the day 5 the cultured embryos were graded according to Gardner's grading system for blastocysts. Then follicular fluids specimens were divided following the different scores given to the respective blastocysts, and their content in myo-inositol was quantified. In each sample of follicular fluid myo-inositol levels were assessed. The quantitative analysis was performed by means of gas chromatography-mass spectrometry (GC-MS) and the values were expressed as µmol/l. This value was related to the respective blastocyst grade.
D-chiro-inositol concentration (µmol/l) in follicular fluid5th day from pick upAfter transvaginal aspiration of oocyte and follicular fluid and subsequent ICSI, at the day 5 the cultured embryos were graded according to Gardner's grading system for blastocysts. Then follicular fluids specimens were divided following the different scores given to the respective blastocysts, and their content in D-chiro-inositol was quantified. In each sample of follicular fluid D-chiro-inositol levels were assessed. The quantitative analysis was performed by means of gas chromatography-mass spectrometry (GC-MS) and the values were expressed as µmol/l. This value was related to the respective blastocyst grade.

Countries

Greece

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 25, 2026